Medicamen Biotech Limited (BOM:531146)

Medicamen Biotech Statistics

Total Valuation

BOM:531146 has a market cap or net worth of INR 4.48 billion. The enterprise value is 4.43 billion.

Market Cap	4.48B
Enterprise Value	4.43B

Important Dates

The next estimated earnings date is Tuesday, February 10, 2026.

Earnings Date	Feb 10, 2026
Ex-Dividend Date	Sep 19, 2025

Share Statistics

BOM:531146 has 12.71 million shares outstanding. The number of shares has decreased by -15.53% in one year.

Current Share Class	12.71M
Shares Outstanding	12.71M
Shares Change (YoY)	-15.53%
Shares Change (QoQ)	-6.31%
Owned by Insiders (%)	5.97%
Owned by Institutions (%)	0.69%
Float	3.99M

Valuation Ratios

The trailing PE ratio is 47.33.

PE Ratio	47.33
Forward PE	n/a
PS Ratio	2.64
PB Ratio	1.63
P/TBV Ratio	1.63
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Enterprise Valuation

The stock's EV/EBITDA ratio is 22.53, with an EV/FCF ratio of -29.19.

EV / Earnings	48.98
EV / Sales	2.61
EV / EBITDA	22.53
EV / EBIT	32.87
EV / FCF	-29.19

Financial Position

The company has a current ratio of 2.61, with a Debt / Equity ratio of 0.14.

Current Ratio	2.61
Quick Ratio	1.42
Debt / Equity	0.14
Debt / EBITDA	1.96
Debt / FCF	-2.54
Interest Coverage	3.80

Financial Efficiency

Return on equity (ROE) is 3.46% and return on invested capital (ROIC) is 4.00%.

Return on Equity (ROE)	3.46%
Return on Assets (ROA)	2.57%
Return on Invested Capital (ROIC)	4.00%
Return on Capital Employed (ROCE)	4.79%
Weighted Average Cost of Capital (WACC)	7.14%
Revenue Per Employee	4.52M
Profits Per Employee	240,771
Employee Count	376
Asset Turnover	0.52
Inventory Turnover	1.30

Taxes

In the past 12 months, BOM:531146 has paid 26.81 million in taxes.

Income Tax	26.81M
Effective Tax Rate	23.98%

Stock Price Statistics

The stock price has decreased by -27.61% in the last 52 weeks. The beta is 0.53, so BOM:531146's price volatility has been lower than the market average.

Beta (5Y)	0.53
52-Week Price Change	-27.61%
50-Day Moving Average	387.56
200-Day Moving Average	388.79
Relative Strength Index (RSI)	39.38
Average Volume (20 Days)	1,067

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, BOM:531146 had revenue of INR 1.70 billion and earned 90.53 million in profits. Earnings per share was 7.45.

Revenue	1.70B
Gross Profit	861.18M
Operating Income	134.89M
Pretax Income	111.81M
Net Income	90.53M
EBITDA	196.80M
EBIT	134.89M
Earnings Per Share (EPS)	7.45

Balance Sheet

The company has 436.79 million in cash and 386.49 million in debt, with a net cash position of 50.31 million or 3.96 per share.

Cash & Cash Equivalents	436.79M
Total Debt	386.49M
Net Cash	50.31M
Net Cash Per Share	3.96
Equity (Book Value)	2.75B
Book Value Per Share	161.11
Working Capital	1.38B

Cash Flow

In the last 12 months, operating cash flow was -120.72 million and capital expenditures -31.17 million, giving a free cash flow of -151.89 million.

Operating Cash Flow	-120.72M
Capital Expenditures	-31.17M
Free Cash Flow	-151.89M
FCF Per Share	-11.95

Margins

Gross margin is 50.68%, with operating and profit margins of 7.94% and 5.33%.

Gross Margin	50.68%
Operating Margin	7.94%
Pretax Margin	6.58%
Profit Margin	5.33%
EBITDA Margin	11.58%
EBIT Margin	7.94%
FCF Margin	n/a

Dividends & Yields

This stock pays an annual dividend of 1.00, which amounts to a dividend yield of 0.27%.

Dividend Per Share	1.00
Dividend Yield	0.27%
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	14.05%
Buyback Yield	15.53%
Shareholder Yield	15.81%
Earnings Yield	2.02%
FCF Yield	-3.39%

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value
Lynch Upside
Graham Number
Graham Upside

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

Altman Z-Score	n/a
Piotroski F-Score	4